ConductScience.org, home

Paper3815420

Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.

Berry J and 2 others. Cancer Immunol Immunother, 1987. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide. Papers, record 3815420. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3815420

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2024-04-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berry JJ
2Green BJB J
3Matheson DSD S

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglutethimideMajor topic
Breast NeoplasmsMajor topic
Killer Cells, NaturalMajor topic
Aged
Cell Line
Cytotoxicity, Immunologic
Estradiol
Female
Humans
Menopause
Middle Aged

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16221746Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6221746PubMed
23919830Variation in natural killer activity in peripheral blood during the menstrual cycle.Br Med J (Clin Res Ed)1985https://conductscience.org/library/papers/3919830PubMed
37334070Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.J Clin Immunol1981https://conductscience.org/library/papers/7334070PubMed
46682769Aminoglutethimide for the treatment of advanced postmenopausal breast cancer.Eur J Cancer Clin Oncol1983https://conductscience.org/library/papers/6682769PubMed
57138766Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.Br J Cancer1982https://conductscience.org/library/papers/7138766PubMed
64688315Source of estrogen production in postmenopausal women.J Clin Endocrinol Metab1973https://conductscience.org/library/papers/4688315PubMed
76420047Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6420047PubMed
86684948Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.Br J Cancer1983https://conductscience.org/library/papers/6684948PubMed
96249490The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast.Cancer1980https://conductscience.org/library/papers/6249490PubMed
10722074beta-Estradiol reduces natural killer cells in mice.J Immunol1978https://conductscience.org/library/papers/722074PubMed
11194681Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.Cancer1977https://conductscience.org/library/papers/194681PubMed
12263348Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.J Clin Endocrinol Metab1978https://conductscience.org/library/papers/263348PubMed
134015950Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.Br J Cancer1985https://conductscience.org/library/papers/4015950PubMed
146944530Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.J Natl Cancer Inst1981https://conductscience.org/library/papers/6944530PubMed
156977516Trimethoprim-induced augmentation of human natural killer activity in vitro.Immunopharmacology1982https://conductscience.org/library/papers/6977516PubMed
167085128Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function.Int J Cancer1982https://conductscience.org/library/papers/7085128PubMed
173981483Hormonal modulation of human natural killer cell activity in vitro.J Reprod Immunol1985https://conductscience.org/library/papers/3981483PubMed
18163658Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.Blood1975https://conductscience.org/library/papers/163658PubMed
1925290166Do NK cells play a role in anti-tumor surveillance?Immunol Today1980https://conductscience.org/library/papers/25290166PubMed
204054302Oestrogen as an inhibitor of human NK cell cytolysis.FEBS Lett1985https://conductscience.org/library/papers/4054302PubMed

See all 21 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
38590244
Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy.
Integr Cancer Ther2024https://conductscience.org/library/papers/38590244PubMed
26455641Endocrine resistance in breast cancer--An overview and update.Mol Cell Endocrinol2015https://conductscience.org/library/papers/26455641PubMed
8738607Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8738607PubMed
8738601Animal models of breast cancer: their diversity and role in biomedical research.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8738601PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3815420

GET https://conductscience.org/api/papers/v1/3815420/references?page=2